Clinical Trial Update: Vit D3 and Omega 3 in Chemo Induced Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vitamin D3 and omega-3 fatty acids for chemotherapy-induced neuropathy in cancer patients. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Peripheral Neuropathy

Drugs mentioned

• Cholecalciferol (Vitamin D3)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Cancer, Neuropathy | Phase 3 | Status: UNKNOWN